4//SEC Filing
Keeney Adam 4
Accession 0001127602-25-003960
CIK 0000875045other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 6:51 PM ET
Size
10.5 KB
Accession
0001127602-25-003960
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
Keeney Adam
Head of Corporate Development
Transactions
- Tax Payment
Common Stock
2025-02-07$141.35/sh−563$79,580→ 1,900 total - Exercise/Conversion
Restricted Stock Unit
2025-02-07−1,801→ 3,604 totalExercise: $0.00Exp: 2027-02-07→ Common Stock (1,801 underlying) - Exercise/Conversion
Common Stock
2025-02-07+1,801→ 2,463 total - Award
Restricted Stock Unit
2025-02-06+9,835→ 9,835 totalExercise: $0.00Exp: 2028-02-06→ Common Stock (9,835 underlying)
Footnotes (2)
- [F1]The restricted stock units vest in three equal yearly installments beginning on the first anniversary of the grant date of February 6, 2025.
- [F2]The restricted stock units vest in three (3) equal annual installments, commencing one year after the grant date of 02/07/2024.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001973607
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 6:51 PM ET
- Size
- 10.5 KB